CN218871043U

CN218871043U - Novel uterus oviduct liquid passing tube

Info

Publication number: CN218871043U
Application number: CN202222109500.1U
Authority: CN
Inventors: 赵真; 陈翠; 谭健; 刘佳; 李静
Original assignee: Affiliated Hospital of Weifang Medical University
Current assignee: Affiliated Hospital of Weifang Medical University
Priority date: 2022-08-11
Filing date: 2022-08-11
Publication date: 2023-04-18
Anticipated expiration: 2032-08-11

Abstract

The utility model discloses a novel uterus oviduct lead to liquid pipe, the utility model relates to a medical instrument technical field, it includes the uterine cavity pipe to lead to the liquid main part, the connecting pipe, lead to liquid appearance pipe and syringe pipe, the fixed intercommunication in uterine cavity pipe one end has the cross-tube connection, the fixed intercommunication of one of them joint and connecting pipe of cross-tube connection, two other joints of cross-tube connection are fixed the intercommunication respectively and are had first gasbag and second gasbag, the fixed intercommunication of one end that the cross-tube connection was kept away from to the connecting pipe has the tee bend connection, one of them joint of tee bend connection and the fixed intercommunication of syringe pipe, the other joint of tee bend connection with lead to the fixed intercommunication of liquid appearance pipe, through the connecting pipe that sets up, tee bend connection and cross-tube connection, reduce to lead to the chance that the liquid pipe main part received the pollution, through promoting the connecting pipe, the length of lumen pipe and fixed pipe, make things convenient for the device to treat special size like obesity, the disabled patient.

Description

Novel uterus oviduct liquid through tube

Technical Field

The utility model relates to the technical field of medical equipment, in particular to a novel uterus oviduct liquid-passing tube.

Background

The uterus oviduct liquid-passing device used in the clinical work at present is mostly composed of three parts, namely a disposable connector, a disposable uterus angiography tube and a disposable injector, wherein the three parts are independent from each other, and the three parts are packaged on a sterile operating table respectively in the clinical use process and are connected with a liquid-passing instrument through a connecting port of the connector.

The prior art has the following problems:

1. the three-part package needs to be opened, so that the pollution risk exists;

2. the connection process of each device is time consuming;

3. the use of a disposable syringe has resource waste;

4. it is inconvenient for patients who are obese or disabled.

SUMMERY OF THE UTILITY MODEL

Aiming at the defects of the prior art, the utility model provides a novel uterus oviduct liquid-passing tube, which solves the problem that the prior novel uterus oviduct liquid-passing tube is inconvenient to carry.

In order to achieve the above purpose, the utility model discloses a following technical scheme realizes: the utility model provides a novel uterus oviduct leads to liquid pipe, includes to lead to liquid pipe main part, lead to liquid pipe main part including palace chamber pipe, connecting pipe, leading to liquid appearance pipe and syringe pipe, the fixed intercommunication in palace chamber pipe one end has the cross-tube connection, one of them joint of cross-tube connection and the fixed intercommunication of connecting pipe, two other joints of cross-tube connection are fixed respectively and are communicated and have first gasbag and second gasbag, the fixed intercommunication of one end that the cross-tube connection was kept away from to the connecting pipe has the tee bend connection, one of them joint of tee bend connection communicates with the syringe is managed is fixed, the other joint of tee bend connection communicates with lead to liquid appearance pipe is fixed.

Furthermore, an inner air bag and an outer air bag are arranged at one end of the uterine cavity tube, which is far away from the four-way pipe joint, and the length of the uterine cavity tube is 40-45 CM.

Furthermore, a Robert clamp is arranged between the four-way pipe joint and the second air bag, and the length of a fixing pipe between the four-way pipe joint and the second air bag is 10-12 CM.

Furthermore, the length of the connecting pipe is 95-100 CM, and the tee joint is of a Y-shaped structure.

Furthermore, one end of the injector tube, which is far away from the tee pipe joint, is communicated with a 50ML injector, and an anti-backflow valve is arranged inside one end of the liquid-passing instrument tube, which is far away from the tee pipe joint.

Further, the first air bag and the second air bag are both of a double-hole structure, and the air volumes of the first air bag and the second air bag are both 5ML.

Advantageous effects

The utility model provides a novel uterus oviduct liquid passing tube, compared with the prior art, the utility model has the following beneficial effects:

1. this neotype uterus oviduct leads to liquid pipe through connecting pipe, tee bend coupling and the four-way pipe joint that sets up for the device is integration equipment, reduces and leads to the chance that the liquid pipe main part received the pollution, presss from both sides through the robert that sets up, can effectively seal, and easy operation is convenient, practices thrift operating time, through the length that promotes connecting pipe, palace chamber pipe and fixed pipe, makes things convenient for the device to treat special size like obesity, disabled patient.

2. This neotype uterus oviduct leads to liquid pipe through the valve that prevents flowing backwards that sets up, need not to use the baroreceptor who connects the liquid appearance, saves use cost, through the first gasbag and the second gasbag that set up, need not to use disposable syringe to operate, has reduced the wasting of resources.

Drawings

Fig. 1 is a schematic overall structure diagram of the present invention;

FIG. 2 is a schematic structural view of the main body of the liquid through pipe of the present invention;

FIG. 3 is a schematic view of the structure of the middle and outer balloons and the anti-reflux valve of the present invention;

fig. 4 is an enlarged schematic view of a structure in fig. 2.

In the figure: 1. a liquid through pipe main body; 11. a uterine cavity tube; 12. a connecting pipe; 13. a liquid passing instrument tube; 14. a syringe barrel; 15. an inner and an outer air bag; 16. a four-way pipe joint; 17. a first air bag; 18. an anti-regurgitation valve; 19. a second air bag; 110. a Robert clamp; 111. a three-way pipe joint.

Detailed Description

The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention.

Please refer to fig. 1-4, the utility model provides a technical scheme, a novel uterus oviduct leads to liquid pipe, including leading to liquid pipe main part 1, it includes uterine cavity pipe 11 to lead to liquid pipe main part 1, connecting pipe 12, lead to liquid appearance pipe 13 and

injector tube

14, 11 one end of uterine cavity pipe is fixed to be communicated with cross-joint 16, one of them joint and the connecting pipe 12 of cross-joint 16 are fixed to be communicated, two other joints of cross-joint 16 are fixed to be communicated with first gasbag 17 and second gasbag 19 respectively, the one end that cross-joint 16 was kept away from to cross-joint 12 is fixed to be communicated with tee bend pipe joint 111, one of them joint and the injector tube 14 of tee bend pipe joint 111 are fixed to be communicated, another joint and the liquid appearance pipe 13 of tee bend pipe joint 111 are fixed to be communicated.

An inner air bag and an outer air bag 15 are arranged at one end of the uterine cavity tube 11 far away from the four-way tube joint 16, the length of the uterine cavity tube 11 is 40CM-45CM, the top end of the uterine cavity tube 11 is placed into the uterine cavity through a cervical canal, the inner diameter of the uterine cavity tube 11 can be sealed through the inflation of the inner air bag and the outer air bag 15, the backflow can be effectively prevented when the tube is withdrawn, a Robert clamp 110 is arranged between the four-way tube joint 16 and a second air bag 19, the length of a fixed tube between the four-way tube joint 16 and the second air bag 19 is 10CM-12CM, the effective sealing can be carried out through the arranged Robert clamp 110, the operation is simple and convenient, the operation time is saved, the length of a connecting tube 12 is 95CM-100CM, the three-way tube joint 111 is of a Y-shaped structure, and the device is integrated through the arranged connecting tube 12, the three-way tube joint 111 and the four-way tube joint 16, reduce the chance that leads to liquid pipe main part 1 and receive the pollution, through promoting connecting pipe 12, the length of palace chamber pipe 11 and fixed pipe, make things convenient for the device to treat special size like obesity, the disabled patient, the one end intercommunication that tee bend pipe joint 111 was kept away from to syringe pipe 14 has 50ML syringe, it prevents valve 18 that flows back to lead to that the inside one end that tee bend pipe joint 111 was equipped with of liquid appearance pipe 13 was kept away from, through the valve 18 that prevents flowing back that sets up, need not to use the baroreceptor of connecting the liquid appearance, use cost is saved, first gasbag 17 and second gasbag 19 all set up to the diplopore structure,

first gasbag

17 and 19 gas volume of second gasbag are 5ML, through first gasbag 17 and the second gasbag 19 that set up, need not to use disposable syringe to operate, the wasting of resources has been reduced.

The working principle is as follows: put into the palace chamber through the cervical canal with 11 tops of palace chamber pipe, inside and outside gasbag 15 is aerifyd and to be closed 11 internal diameters of palace chamber pipe, can effectively prevent the refluence when withdrawing the pipe, through the robert's clamp 110 that sets up, can effectively seal, and easy operation is convenient, save operating time, through the connecting pipe 12 that sets up, three-way pipe joint 111 and four-way pipe joint 16, make the device equipment as an organic whole, reduce the chance that leads to liquid pipe main part 1 and receive the pollution, through promoting connecting pipe 12, the length of palace chamber pipe 11 and fixed tube, make things convenient for the device to treat special size like obesity, the patient of disability, through the valve 18 that prevents backflowing who sets up, need not to use the baroreceptor of connecting the liquid appearance, use cost is saved, through first gasbag 17 and the second gasbag 19 that set up, need not to use disposable syringe to operate, the wasting of resources has been reduced.

Claims

1. A novel uterus oviduct liquid passing tube comprises a liquid passing tube main body (1) and is characterized in that: lead to liquid pipe main part (1) including palace chamber pipe (11), connecting pipe (12), lead to liquid appearance pipe (13) and syringe pipe (14), palace chamber pipe (11) one end is fixed to be communicated with cross tube joint (16), one of them joint and the fixed intercommunication of connecting pipe (12) of cross tube joint (16), two other joints of cross tube joint (16) are fixed the intercommunication respectively and have first gasbag (17) and second gasbag (19), the fixed intercommunication of one end that cross tube joint (16) was kept away from in connecting pipe (12) has tee bend coupling (111), one of them joint and the fixed intercommunication of syringe pipe (14) of tee bend coupling (111), the other joint and the fixed intercommunication of liquid appearance pipe (13) of tee bend coupling (111).

2. The new uterine tube passing tube as claimed in claim 1, wherein: an inner air bag and an outer air bag (15) are arranged at one end of the uterine cavity tube (11) far away from the four-way pipe joint (16), and the length of the uterine cavity tube (11) is 40-45 CM.

3. The new uterine tube passing tube as claimed in claim 1, wherein: a Robert clamp (110) is arranged between the four-way pipe joint (16) and the second air bag (19), and the length of a fixing pipe between the four-way pipe joint (16) and the second air bag (19) is 10-12 CM.

4. The new uterine tube passing tube as claimed in claim 1, wherein: the length of the connecting pipe (12) is 95-100 CM, and the tee joint pipe joint (111) is of a Y-shaped structure.

5. The new uterine tube passing tube as claimed in claim 1, wherein: and one end of the injector pipe (14) far away from the three-way pipe joint (111) is communicated with a 50ML injector, and the inside of one end of the liquid-passing instrument pipe (13) far away from the three-way pipe joint (111) is provided with an anti-backflow valve (18).

6. The new uterine tube passing tube as claimed in claim 1, wherein: the first air bag (17) and the second air bag (19) are both of a double-hole structure, and the air volumes of the first air bag (17) and the second air bag (19) are both 5ML.